Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity

被引：23

作者：

Clader, JW ^{[1
]}

Billard, W ^{[1
]}

Binch, H ^{[1
]}

Chen, LY ^{[1
]}

Crosby, G ^{[1
]}

Duffy, RA ^{[1
]}

Ford, J ^{[1
]}

Kozlowski, JA ^{[1
]}

Lachowicz, JE ^{[1
]}

Li, SJ ^{[1
]}

Liu, C ^{[1
]}

McCombie, SW ^{[1
]}

Vice, S ^{[1
]}

Zhou, GW ^{[1
]}

Greenlee, WJ ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2004年 / 12卷 / 02期

关键词：

D O I：

10.1016/j.bmc.2003.11.005

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 [生物化学与分子生物学]; 081704 [应用化学];

摘要：

引用

页码：319 / 326

页数：8

共 18 条

[1]

*ACS, 2000, 221 M AM CHEM SOC

[2]

Diphenylsulfone muscarinic antagonists:: Piperidine derivatives with high M2 selectivity and improved potency [J].

Billard, W ;

Binch, H ;

Bratzler, K ;

Chen, LY ;

Crosby, G ;

Duffy, RA ;

Dugar, S ;

Lachowicz, J ;

McQuade, R ;

Pushpavanam, P ;

Ruperto, VB ;

Taylor, LA ;

Clader, JW .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) :2209-2212

[3]

BILLARD W, 1995, J PHARMACOL EXP THER, V273, P273

[4]

Enhancement of pharmacokinetic properties and in vivo efficacy of benzylidene ketal M2 muscarinic receptor antagonists via benzamide modification [J].

Boyle, CD ;

Vice, SF ;

Campion, J ;

Chackalamannil, S ;

Lankin, CM ;

McCombie, SW ;

Billard, W ;

Binch, H ;

Crosby, G ;

Williams, MC ;

Coffin, VL ;

Cox, KA ;

Grotz, DE ;

Duffy, RA ;

Ruperto, V ;

Lachowicz, JE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) :3479-3482

[5]

Metabolic stabilization of benzylidene ketal M2 muscarinic receptor antagonists via halonaphthoic acid substitution [J].

Boyle, CD ;

Chackalamannil, S ;

Clader, JW ;

Greenlee, WJ ;

Josien, HB ;

Kaminski, JJ ;

Kozlowski, JA ;

McCombie, SW ;

Nazareno, DV ;

Tagat, JR ;

Wang, YG ;

Zhou, GW ;

Billard, W ;

Binch, H ;

Crosby, G ;

Cohen-Williams, M ;

Coffin, VL ;

Cox, KA ;

Grotz, DE ;

Duffy, RA ;

Ruperto, V ;

Lachowicz, JE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (17) :2311-2314

[6]

Benzylidene ketal derivatives as M2 muscarinic receptor antagonists [J].

Boyle, CD ;

Chackalamannil, S ;

Chen, LY ;

Dugar, S ;

Pushpavanam, P ;

Billard, W ;

Binch, H ;

Crosby, G ;

Cohen-Williams, M ;

Coffin, VL ;

Duffy, RA ;

Ruperto, V ;

Lachowicz, JE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (24) :2727-2730

[7]

Clader J W, 1999, Curr Opin Drug Discov Devel, V2, P311

[8]

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease [J].

Greenlee, W ;

Clader, J ;

Asberom, T ;

McCombie, S ;

Ford, J ;

Guzik, H ;

Kozlowski, J ;

Li, S ;

Liu, C ;

Lowe, D ;

Vice, S ;

Zhao, H ;

Zhou, G ;

Billard, W ;

Binch, H ;

Crosby, R ;

Duffy, R ;

Lachowicz, J ;

Coffin, V ;

Watkins, R ;

Ruperto, V ;

Strader, C ;

Taylor, L ;

Cox, K .

FARMACO, 2001, 56 (04) :247-250

[9]

Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery [J].

Korfmacher, WA ;

Cox, KA ;

Ng, KJ ;

Veals, J ;

Hsieh, YS ;

Wainhaus, S ;

Broske, L ;

Prelusky, D ;

Nomeir, A ;

White, RE .

RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2001, 15 (05) :335-340

[10]

Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor [J].

Kozlowski, JA ;

Lowe, DB ;

Guzik, HS ;

Zhou, GW ;

Ruperto, VB ;

Duffy, RA ;

McQuade, R ;

Crosby, G ;

Taylor, LA ;

Billard, W ;

Binch, H ;

Lachowicz, JE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) :2255-2257

← 1 2 →